Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether + lumefantrine for uncomplicated falciparum malaria in Somalia
ACTRN12617001055392Phase 4Completed
- Sponsor
- Department of Health and Human Services
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in Malaria, sponsored by Department of Health and Human Services. Primary endpoints: Treatment failure rate and Adequate clinical and parasitological response. Started Aug 2017; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12617001055392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001055392.